0001411207-19-000209.txt : 20191112
0001411207-19-000209.hdr.sgml : 20191112
20191112140516
ACCESSION NUMBER: 0001411207-19-000209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191108
FILED AS OF DATE: 20191112
DATE AS OF CHANGE: 20191112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASKREN STANLEY A
CENTRAL INDEX KEY: 0001195347
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35456
FILM NUMBER: 191208507
MAIL ADDRESS:
STREET 1: 408 EAST SECOND STREET
CITY: MUSCATINE
STATE: IA
ZIP: 52761
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allison Transmission Holdings Inc
CENTRAL INDEX KEY: 0001411207
STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE ALLISON WAY
CITY: Indianapolis
STATE: IN
ZIP: 46222
BUSINESS PHONE: (317) 242-5000
MAIL ADDRESS:
STREET 1: ONE ALLISON WAY
CITY: Indianapolis
STATE: IN
ZIP: 46222
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-11-08
0001411207
Allison Transmission Holdings Inc
ALSN
0001195347
ASKREN STANLEY A
ONE ALLISON WAY
INDIANAPOLIS
IN
46222
1
0
0
0
Deferred Stock Units
2019-11-08
4
A
0
454
0
A
Common Stock
454
3824
D
These deferred stock units ("DSUs") respresent a quarterly payment of the reporting person's annual retainer under the Allison Transmission Holdings, Inc. (the "Company") Third Amended and Restated Non-Employee Director Compensation Policy ("Policy") deferred pursuant to the Company's Amended and Restated Non-Employee Director Deferred Compensation Plan. The annual retainer is paid quarterly in arrears.
Each DSU is the economic equivalent of one share of the Company's Common Stock. The DSUs become payable, in common stock or at the Company's election cash, at the earlier of the reporting person's separation from service or a change in control. DSUs earn dividend equivalents when dividends are declared on the Company's common stock.
The number of DSUs received was calculated based on $46.75, which was the closing price of the Company's common stock on the date of grant.
/s/Jacalyn C. Bolles, Attorney-in-Fact
2019-11-12